Revenues, Recognition and Allowances (Tables)

12 Months Ended

Dec. 31, 2018

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenues

Net Sales (in thousands) for the three years ended December 31, 2018, 2017 and 2016 were as follows (prior-period amounts are not adjusted under the modified-retrospective method of adoption):

	Years ended December 31,
	2018		2017		2016
Company product sales	$	59,591	$	50,955	$	45,002
Contract manufacturing sales	6,047		8,995		17,033
Research and development services and other income	227		252		977
Revenue, net	$	65,865	$	60,202	$	63,012

Disaggregated information for the Company product sales revenue has been recognized in the accompanying audited Consolidated Statements of Operations, and is presented below according to contract type (in thousands):

	Years ended December 31,
Company Product Sales	2018		2017		2016
Topical	$	35,118	$	29,446	$	29,011
Injectables	24,473		21,509		15,991
Total	$	59,591	$	50,955	$	45,002

Schedule of Financing Receivable

The Company's adjustments for the deductions to gross product sales for the three years ended December 31, 2018, 2017 and 2016 are as follows (in thousands):

	Years ended December 31,
	2018		2017		2016
Gross product sales	$	158,278	$	215,883	$	217,633
Reduction to gross product sales:
Chargebacks and billbacks	60,770		125,159		141,343
Wholesaler fees for service	5,503		7,049		3,869
Sales discounts and other allowances	32,414		32,720		27,419
Total reduction to gross product sales	$	98,687	$	164,928	$	172,631
Product sales, net	$	59,591	$	50,955	$	45,002
Contract manufacturing product sales	$	6,047	$	8,995	$	17,033
Total product sales, net	$	65,865	$	60,202	$	63,012

Schedule Of Annual Activity Allowance For Customer Deductions Disclosure